Pradžia › Šizofrenija › New Jersey
Šizofrenija klinikiniai tyrimai New Jersey
13 tyrimai dėl Šizofrenija ieško dalyvių vietose New Jersey.
Miestai New Jersey
Oficialus tyrimo tekstas (anglų kalba)
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Hackensack Meridian Health - Carrier Clinic, Belle Mead
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07101094NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Site, Marlton
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07114874Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
- Neurocrine Clinical Site, Marlton
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07227818A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0146, Neptune City
Renkami dalyviai3 fazė
Amžius nuo 5 iki 17 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07424404A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
- Hassman Research Institute, LLC, Marlton
Renkami dalyviai1 fazė
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-09-17 · NCT07734493A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
- Cenexel Hassman Research Institute (Hri) /ID# 276128, Marlton
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-15 · NCT07145918A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
- Hassman Research Institute Marlton Site, Marlton
Renkami dalyviai1 fazė
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Marlton
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-01 · NCT07459647A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Cenexel HRI, Marlton
Renkami dalyviai2 fazė
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-06-23 · NCT07191483A Study to Evaluate the Effect of KarXT on Urological Safety
- Hassman Research Institute Marlton Site, Marlton
Renkami dalyviai4 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-06-03 · NCT07221877Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
- Center for Advanced Human Brain Imaging Research, Piscataway
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 50 · Visoms lytims · Atnaujinta 2026-03-11 · NCT06745479NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, Marlton
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-03-06 · NCT06963034Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Marlton
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-01-12 · NCT06961968Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.